Double-stranded RNA (dsRNA) activates the innate immune system of mammalian cells and triggers intracellular RNA decay by the pseudokinase and endoribonuclease RNase L. RNase L protects from pathogens and regulates cell growth and differentiation by destabilizing largely unknown mammalian RNA targets. We developed an approach for transcriptome-wide profiling of RNase L activity in human cells and identified hundreds of direct RNA targets and nontargets. We show that this RNase L-dependent decay selectively affects transcripts regulated by microRNA (miR)-17/miR-29/miR-200 and other miRs that function as suppressors of mammalian cell adhesion and proliferation. RNase L mimics the effects of these miRs and acts as a suppressor of proliferation and adhesion in mammalian cells. Our data suggest that RNase L-dependent decay serves to establish an antiproliferative state via destabilization of the miRregulated transcriptome.
Double-stranded RNA (dsRNA) activates the innate immune system of mammalian cells and triggers intracellular RNA decay by the pseudokinase and endoribonuclease RNase L. RNase L protects from pathogens and regulates cell growth and differentiation by destabilizing largely unknown mammalian RNA targets. We developed an approach for transcriptome-wide profiling of RNase L activity in human cells and identified hundreds of direct RNA targets and nontargets. We show that this RNase L-dependent decay selectively affects transcripts regulated by microRNA (miR)-17/miR-29/miR-200 and other miRs that function as suppressors of mammalian cell adhesion and proliferation. RNase L mimics the effects of these miRs and acts as a suppressor of proliferation and adhesion in mammalian cells. Our data suggest that RNase L-dependent decay serves to establish an antiproliferative state via destabilization of the miRregulated transcriptome.
Nase L is a mammalian endoribonuclease regulated by the action of dsRNA and IFNs α/β/λ, which induce the intracellular synthesis of a specific RNase L activator, 2-5A (1). RNA cleavage is thought to account for all biological functions of the RNase L·2-5A complex, including innate immunity during the IFN response (2, 3) , and regulation of cell cycle (4), proliferation (5) , adipocyte differentiation (6) , and apoptosis (7) . RNase L inhibits translation by site-specific cleavage of 18S and 28S rRNA (8) and activates transcription and the inflammasome NLRP3 by releasing signaling RNA fragments (2, 9, 10). These mechanisms complement or operate in parallel with posttranscriptional gene control via regulated decay of some mRNAs, including myogenic regulatory factor MyoD (11) , components of IFN signaling ISG43 and ISG15 (12) , translation-inhibiting kinase PKR (13) , cathepsin E gastric protease (3), 3′-UTRbinding protein HuR (4) , as well as ribosomal and mitochondrial protein-encoding mRNAs (14) (15) (16) . Although the repression of these transcripts depends on RNase L, it remains unknown how many of them are cleaved physically and how many are downregulated indirectly-for example, via transcription.
A recent RNA-sequencing (RNA-seq) study described some of the direct targets of RNase L (8) . Cleavages were reported for 18S rRNA and U6 snRNA, however the experiment was designed to detect predominantly ribosomal reads and the direct impact of RNase L on mRNAs was not defined. Structural and biochemical studies found that RNase L cleaves RNA at the consensus sequence UN^N (N = A, U, G, or C;^is the cleavage location) (17) (18) (19) . The UN^N motifs are abundant in all mammalian RNAs, suggesting that RNase L may degrade every mRNA it encounters, which surprisingly contrasts regulation of RNase L by the highly specific stimuli dsRNA, IFNs, and 2-5A.
Mammalian cells contain a transmembrane RNase L homolog, a kinase/RNase Ire1, which drives the unfolded protein response and regulated Ire1-dependent decay (RIDD) (18, 20) . The cleavage consensus sequence of Ire1 (UĜC) is similarly relaxed, however Ire1 targets only specific mRNAs. The specificity is achieved by colocalization with cognate mRNAs at the ER membrane (21) . For the cytosolic enzyme RNase L, such a specificity mechanism is not documented. To understand mammalian gene regulation by RNase L, we mapped RNase L-dependent decay (RLDD) in human cells. We show that RNase L does not cleave all cellular transcripts and identify biologically related groups of RLDD targets and nontargets.
Results
Direct Cleavage of Human Transcripts by RNase L. To observe cleavage of human transcripts by RNase L and minimize offpathway effects from RNase L-independent decay and transcription, we used HeLa S10 extracts. This approach removes the nucleus and the plasma membrane and permits selective and rapid RNase L activation. We exposed the human transcriptome to activated RNase L using two complementary techniques and used either synthetic 2-5A to activate endogenous RNase L (Fig. 1A) or crystallization-purity recombinant human RNase L premixed with 2-5A. Both techniques activate RNase L and produce the characteristic pattern of 28S rRNA cleavage (Fig. 1B) .
We analyzed the resulting RNA samples using poly-A + RNAseq, which captures the poly-A tails and reveals cleavage by the loss of 5′-terminal reads (Fig. 1C) . Incubation of untreated S10 extracts had no considerable effects on the mRNA levels ( Fig.  S1A ), whereas addition of 2-5A or the RNase L·2-5A complex produced a broad response (Fig. S1 B and C and Dataset S1). We identified transcripts that exhibited a strong loss of reads (targets) as well as transcripts that remained intact (nontargets; Fig. 1C ). The levels of multiple mRNAs fell by 100-1,000-fold when most of the 28S rRNA was still uncleaved (Fig. 1B, "2" ). Based on this quantification, the ribosomes are not the preferred targets of RNase L and mRNA cleavage may be substantial even
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Data deposition: The data reported in this paper have been deposited in the Gene Expression Omnibus (GEO) database, www.ncbi.nlm.nih.gov/geo (accession no. GSE75530). when 28S rRNA is visibly intact. Seven previously reported mRNA targets of RNase L (22) were abundant sufficiently for detection in our samples. Five were cleaved weakly, whereas two (TTP and ISG15) were resistant and belonged to nontargets (Fig. 1D) . None belong to 2,000 most strongly cleaved transcripts ( Fig. 1D and Dataset S1).
RNase L cleaves the UNN pattern but prefers UU^N and UÂN sites in model substrates (17, 23) . The UU/UA preference is recapitulated in our RNA-seq data (Fig. 1E) . We extended this analysis to other sequences and calculated running average counts for a number of motifs. To account for the higher frequency of shorter sequences (such as UU) compared with longer sequences (such as UUUUU), we normalized the running averages by the net average of the dataset and graphed the profiles from the same origin. As a baseline, we plotted the running average of mRNA length, which does not depend on mRNA sequence. The targets of RNase L are generally longer than nontargets, likely due to the presence of more phosphodiester bonds and more opportunities for cleavage of these mRNAs (Fig. 1F) . Nucleotides G and C accumulate more slowly than the length, indicating that these bases are negatively selected in RNase L targets. Nucleotides U and A are positively selected, consistent with the reported U > A>>G > C preference of RNase L (23). Motifs UU/UA and UUUUU/AAAAA are enriched in targets, however even stronger enrichment occurs for patterns AUUUA and UAUAU (Fig. 1F ). These enrichments cannot be accounted for by the natural composition of long versus short transcripts (Fig. 1G ). The AUUUA pattern is a known stability element (AU-rich element) found usually in the 3′-UTRs of mRNAs (24) . The UAUAU motif is also enriched in the 3′-UTRs (Fig. 1H ) and often co-occurs with the AUUUA motif (Fig. S1D , R 2 = 0.68). The AUUUA/UAUAU sequence preference is not encoded in the RNase L protein (18) , therefore our data must reflect the properties of the mRNAs that have these motifs. These mRNAs could be more accessible to RNase L, have a higher tendency to exist in locally single-stranded structures, or have bound helper proteins. The elevated abundance of the AUUUA/UAUAU sites is not the only determinant of RNase L cleavage, as indicated by the large vertical scatter in Fig. 1E and Fig. S1E . Presently unknown features independent from the AU-rich element abundance, such as mRNA localization, binding of proteins or microRNAs, or the identity of translated proteins, must further distinguish the targets of RLDD.
RNase L Selects MicroRNA-Regulated mRNAs. By combining the data from both RNA-seq strategies, we assembled the lists of RNase L targets (S10+ signatures) and nontargets (S10-signatures) ( Fig.  2A and Dataset S1). These S10 signatures provide the reference for evaluation of mechanistic RNase L activity in high-throughput datasets. To this end, we used a probability-based approach that uses signed P′ calculations (SI Methods). This method shows positive peaks in the regions of data that have enrichments for signature genes, negative peaks where the signature genes are depleted (Fig. 2B) , and absence of peaks when the gene order is random (Fig. S2A) . We used the signed P′ analysis as a standard procedure for evaluating RNase L activity in subsequent RNAseq experiments.
To define the biological activities of RLDD, we used GSEA (Gene Set Enrichment Analysis) (25) . We expanded the standard GSEA library (10,295 gene sets) by 9,492 gene sets [RathKorennykh (RK) signatures, Dataset S2], which we derived from published annotation sources (26, 27) . We additionally created two RK subsets with many and few UAUAU motifs, which are intrinsically enriched for targets and nontargets of RNase L, respectively. GSEA found that RNase L nontargets encode predominantly ribosomal and mitochondrial proteins. A false discovery rate (FDR) of <0.25 (25) was observed for gene groups "KEGG ribosome," "cytosolic ribosome," "respiratory electron transport," "mitochondria," and related terms (Fig. 2C) . Notably, ribosomal and mitochondrial mRNAs have been previously proposed to be the targets of RNase L (14-16), whereas we do not see down-regulation of these transcripts, indicating that RLDD does not destabilize them directly. The targets of RNase L are enriched for "zinc finger," "plasma membrane," and related gene sets ( Fig.  2C and Fig. S2B ). The enrichment for zinc fingers, many of which are transcription factors (TFs), suggests a possible cause of transcriptional (10) gene regulation by RNase L. The UAUAU-rich signatures show similar enrichments as well as enrichments for "membrane," "N-linked," "GlcNAc," "extracellular," and related terms, indicating degradation of many ER-targeted transcripts.
GSEA shows further that the RLDD targets are strongly enriched for transcripts regulated by the microRNAs miR-21, miR-30, miR-155, miR-192, and miR-200 (Fig. 2C , GSEA and RK data). These microRNAs regulate cell cycle, growth, proliferation, apoptosis, carcinogenesis, and adipogenesis (28) (29) (30) (31) , which recapitulates the known repertoire of RNase L (7, (32) (33) (34) profiling of conserved microRNA targets from TargetScan 6 (35) . This analysis confirmed an extensive overlap between RLDD and microRNA targets (Fig. 2C , TargetScan and Fig. S2C ). Because our RNA-seq experiments detect the direct action of RNase L (Fig.  1A) , RNase L physically cleaves the mRNA targets of microRNAs rather than destabilizes them via microRNA modulation.
RLDD Is Conserved in Live Cells and Across Cell Types. To confirm that S10 extracts reflect RLDD in live cells, we sequenced RNA from HeLa cells overexpressing WT RNase L or the catalytically inactive point mutant H672N (18) . Overexpressed WT RNase L was active due to either endogenous dsRNA (36) or autonomous self-association (37), whereas the H672N mutant was inactive. Signed P′ analysis of S10-and S10+ signatures and GSEA profiles in these experiments show that RLDD targets the same mRNA groups in cells and in S10 extracts (Fig. S3) . Similar results were obtained using RNAi-knockdown (KD) experiments. The RNAi approach provided 60-80% RNase L KDs in HeLa cells relative to scrambled siRNA controls (Fig. S4A) . To activate RNase L in WT and KD cells, we used poly-inosine/ cytosine (poly-I:C), a synthetic dsRNA that triggers the IFN response, 2-5A synthesis, and 28S rRNA cleavage ( Fig. S4B and Dataset S1). Compared with controls, KD cells showed stabilization of S10+ signatures (Fig. S4C) and GSEA enrichments as in S10 extracts (Fig. S4D) . RNAi data thus further confirm the conservation of RLDD between S10 extracts and live cells.
To evaluate whether our findings in HeLa extend to other cell types, we profiled RLDD in T47D human cells. T47D cells express more RNase L than HeLa cells, which allows fast activation of endogenous RNase L while preserving the cellular architecture better than using S10 extracts. Toward this end, we developed an in situ semipermeabilization procedure based on the recent study of receptor Stimulator of Interferon Genes (STING) activation by the second messenger 2′,3′-cGAMP (cyclic GMP-AMP) (38) (Fig.  3A) . T47D cells were incubated for 1, 3, and 9 min with digitonin ± 2-5A ( Fig. 3B and Fig. S5 ), and the mRNA samples were analyzed by poly-A + RNA-seq. These data revealed the same targets and nontargets as in HeLa extracts and HeLa cells (Fig. 3 C-E) , demonstrating conservation of RLDD in another cell line.
Posttranscriptional and Transcriptional Axes of RLDD. The knowledge of physical mRNA targets and nontargets allows profiling of the RNase L program with a considerable resolution. Here we built on this knowledge to evaluate the functions of RLDD in homeostasis and examined the transcriptomes of human WT and RNase L-knockout (KO) cells. These experiments extended our coverage to another cell line (HAP1) and defined the physiological effect of RNase L in the presence versus functional absence (Fig. 4A) Signed P′ analysis revealed characteristic RLDD profiles in poly-A + data and in the ratio Exons/(Introns + Exons) in RiboZero samples (Fig. 4B) . In contrast, Ribo-Zero intron data had an inverse S10+ profile and a flat S10-profile (Fig. 4B) . Our results can be explained by an approximation that changes in the poly-A + mRNA levels reflect both transcriptional and posttranscriptional regulation; changes in the intron levels in Ribo-Zero data reflect largely transcriptional regulation, whereas changes in the ratio Exons/(Introns + Exons) in Ribo-Zero data correct for transcription and measure largely posttranscriptional regulation (Fig.  4B) . The inverse enrichment of RNase L signatures in the intron data suggests a compensatory transcriptional response to mRNA destabilization (transcriptional buffering), observed previously during RNA decay by the exonuclease Xrn1 (40) . The global mRNA stabilization in RNase L-KO cells obeys the sequence rules established for direct mRNA cleavage by RNase L in HeLa extracts (Figs. 1F and 4C ), indicating that RLDD is conserved in HAP1 cells and that RNase L is constitutively active in these cells due to endogenous dsRNA (36) or 2-5A-independent RNase L activation (37 HeLa and T47D experiments (Fig. 4D) . In contrast, transcriptional regulation (revealed by intron counting) is considerably different and shows an absence of the heretofore universally observed S10-signatures comprising ribosomal and mitochondrial enrichments (although 82% of the mitochondrial and 92% of the ribosomal transcripts from S10-signatures were covered by the intron data). The levels of multiple TFs (41) are altered in RNase L-KO cells, including TFs involved in proliferation, adipogenesis, insulin response, and adhesion (Fig. 4E) . The majority of the repressed TF mRNAs are not the direct targets of RNase L (Fig. 4E) . However, the transcripts of CTNND1 and ZEB1 are regulated directly by RNase L throughout our study (Dataset S1 (28, 31, 42, 43) . The notion that RNase L shares common targets with these microRNAs suggests that RNase L may exhibit similar physiologic activities. To test whether RNase L regulates proliferation in HAP1 cells, we used a scratch wound healing assay, which has been used previously to evaluate the antiproliferative roles of miR-29 and miR-200 (31, 42, 44) . We observed a rapid wound closure in RNase L-KO cells but not in WT cells, confirming a proliferation suppressor function of RNase L (Fig. 5 A  and B) . The inhibitory action of RNase L on proliferation was also detected in mouse embryonic fibroblast (MEF) RNase L-KO cells and in HeLa cells (Fig. 5B and Fig. S6 ). The inhibitory effect may arise from more than one activity and reflect altered migration, growth, adhesion, or contact inhibition. The importance of RNase L for some of these processes, such as growth and cell cycle, has been documented (4). Here we report a role of RNase L in suppressing adhesion. RNase L down-regulates transcripts involved in adhesion both posttranscriptionally (Fig. 3D , FDR = 0.000-0.002) and transcriptionally (Fig. 4D , FDR = 0.001-0.003). Quantitative PCR (qPCR) of select transcripts confirmed the RNA-seq results ( Fig.  5C and Table S1 ). In HAP1 cells, the adhesion group is detected in poly-A + and intron data, but not in Exons/(Introns + Exons) data, suggesting predominantly a transcriptional down-regulation. In agreement with the RNA-seq data, RNase L-KO HAP1 cells and MEFs adhere rapidly compared with WT cells (Fig. 5D ). The inhibitory effect of RNase L on adhesion could be also observed using overexpression (Fig. S7) . Our results indicate that RNase L is a functional inhibitor of cell proliferation and adhesion at least in the cell lines that we tested.
Discussion
We describe the transcriptome-wide program of mRNA cleavage by RNase L. Our approach identifies nontargets and direct targets shared by three human cell lines. The nontargets have few AUUUA/UAUAU motifs and include ribosomal and mitochondrial protein mRNAs, such as RPL8, RPL11, RPL12, RPL18, MRPL23, ATP5E, ATP5G1, BAX, COX5B, COX6A1, CYBA, NDUFB1, or NDUFB7 (Dataset S1). The targets have many AUUUA/ UAUAU motifs and include membrane, extracellular, and zinc finger protein mRNAs, such as CTNND1, AR, BRCA1, PCDHB5, PCDHB7, AHR, ERBB3, FN1, TMEM154, SEMA6B, ADIPOR2, ZEB1, and ZNF260 (Fig. 5E ). Among strongly cleaved targets are multiple mRNAs encoding secreted and membrane proteins, which must enter the ER lumen for folding and maturation. RLDD thus resembles RIDD (45), a program activated by misfolded proteins inside the ER lumen to establish a negative feedback loop mitigating the ER stress. However, RLDD is not coupled to the ER stress and is activated in response to innate immune cues.
RLDD-sensitive transcripts (S10+ signatures) contain ∼50-60 targets of each miR-17/miR-29/miR-200, whereas RLDDresistant transcripts (S10-signatures) contain 3-4 targets of these microRNAs. The destabilization of common molecular targets coincides with similar biologic effects downstream of RLDD and microRNAs. Upstream, the regulation of RLDD differs from that of microRNAs and depends on the second messenger 2-5A, dsRNA, IFNs, and two phosphodiesterases AKAP7 and PDE12 (46) . These effectors integrate RLDD into the innate immune system and could use the resulting effects on adhesion and proliferation to eliminate infected or damaged cells and control homeostasis. The action of RNase L could be mechanistically independent from that of microRNAs or be synergistic, if microRNA binding opens or blocks access of RNase L to target mRNAs. The model of cooperation between RNase L and microRNAs is indirectly supported by their simultaneous dependence on the mRNA-binding protein TTP (32, 47) . Many of the identified cleaved transcripts encode proteins with known homeostatic and stress response functions, which could explain their destabilization by both microRNAs and RNase L.
Methods
Cell-Based Work. Cells were grown using ATCC (American Type Culture Collection) or provider-recommended conditions in MEM + 10% (vol/vol) FBS (HeLa), RPMI + 10% (vol/vol) FBS (T47D and MEFs), or IMDM + 10% (vol/vol) FBS (HAP1). Recombinant human RNase L for RNA cleavage in extracts was purified as we described previously (18) . We obtained 2-5A by chemical synthesis (ChemGenes) or in house (19) .
RNA-Seq Experiments and Computational Analyses. Total RNA samples were extracted (RNeasy kit, Qiagen), converted into libraries, and sequenced on Illumina HiSEq. 2000 platform. Sequencing reads were mapped to the hg19 human genome using TopHat 2 (48) and counted in HTseq-count (49) .
Signed P′ analyses and RNA pattern analyses were conducted using custom software described in SI Methods and using RefSeq database (26) . GSEA analyses were conducted with GSEA v2.2.0 (25) using preranked procedure. RNA-seq data were visualized in Integrative Genomics Viewer (IGV) (50) . A detailed description of the methods, procedures, and reagents is provided in SI Methods.
Error Analysis. SEs were determined from three biological replicates.
